Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Kaiser Permanente Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Kaiser Permanente Ventures

Kaiser Permanente Ventures

Operating

Kaiser Permanente Ventures: A leading healthcare investment firm, focusing on innovative solutions in digital health, medical devices, and precision medicine.

Location
Oakland, CA, US
Founded
1997
Firm
Compare
Portfolio
Employees
Website

Investments

Abridge
Abridge

Total Raised

$757.5M

Rounds

10

Series C$150MFebruary 2024
Series B$30MOctober 2023
Gynesonics
Gynesonics
Public

Total Raised

$401.8M

Rounds

16

Series Unknown$42.5MOctober 2023
Everytable
Everytable

Total Raised

$112.3M

Rounds

9

Series C$25MJune 2023
Series C$55MAugust 2022
Series B$16MNovember 2020
DexCare
DexCare

Total Raised

$145M

Rounds

3

Series C$75MJune 2023
Series A$20MMarch 2021
Nocd
Nocd

Total Raised

$84M

Rounds

6

Series B$34MJanuary 2023
Series B$33MSeptember 2021
Validic
Validic

Total Raised

$30.4M

Rounds

7

Series Unknown$12MNovember 2022
Kate Farms
Kate Farms

Total Raised

$188M

Rounds

5

Series C$75MSeptember 2022
Series B$51MNovember 2020
Ordr
Ordr

Total Raised

$94M

Rounds

5

Series C$40MJune 2022
IntelyCare
IntelyCare

Total Raised

$170.8M

Rounds

3

Series C$115MApril 2022
Osso VR
Osso VR

Total Raised

$109.2M

Rounds

7

Series C$66MMarch 2022
Series B$27MJuly 2021
Series A$14MSeptember 2020
Big Health
Big Health

Total Raised

$129.3M

Rounds

4

Series C$75MJanuary 2022
Genome Medical
Genome Medical

Total Raised

$120.4M

Rounds

6

Series C$60MAugust 2021
Protenus
Protenus

Total Raised

$57.2M

Rounds

6

Series D$21MJune 2021
Recover Together
Recover Together

Total Raised

$115M

Rounds

6

Series C$60MMay 2021
Evidation Health
Evidation Health

Total Raised

$259M

Rounds

10

Series E$153MMarch 2021
Freenome
Freenome

Total Raised

$1.1B

Rounds

8

Series C$270MAugust 2020
GINGER.IO
GINGER.IO

Total Raised

$222.4M

Rounds

11

Series D$50MAugust 2020